Brief: Novabay Pharmaceuticals Signs Definitive Agreement To Sell Its Avenova Assets
Sept 20 (Reuters) - NovaBay Pharmaceuticals Inc NBY.A :
* NOVABAY PHARMACEUTICALS SIGNS DEFINITIVE AGREEMENT TO SELL
ITS
AVENOVA ASSETS
* NOVABAY PHARMACEUTICALS INC - TO SELL AVENOVA ASSETS TO
PRN FOR
$9.5 MILLION
Source text for Eikon: ID:nBw8cXbB6a
Further company coverage: NBY.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing